Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 250 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Bushra K.

Pakistan

USD 250 /hr

Scientific writing with 10+ years of experience in clinical research. Haematology and statistics expert.

Profile Summary

With over 11 years of clinical research experience and a PhD in Haematology, I bring a robust background in both academic research and clinical trials. My work has been centered around haematological malignancies, clinical trial design and implementation, and scientific publishing.

Subject Matter Expertise

• ☆ Pediatric Medicine
• ☆ Hematology
• ☆ Hematology-Oncology
• ☆ Clinical Laboratory Science
• ☆ Clinical Pathology
• ☆ Molecular Pathology
• ☆ Cytopathology & Histopathology
• ☆ Histopathology
• ☆ Cytopathology
• ☆ Pediatric Hematology-Oncology

Services

• Writing
• Data & AI

Writing Medical Writing, General Proofreading & Editing

Data & AI Statistical Analysis

Work Experience

Senior Research Associate

The Indus Hospital Korangi Campus

2019 - 2023

Clinical Research Associate

National Institute of Blood Diseases and Bone Marrow Transplantation

2011 - 2019

Education

MPhil/PhD (Haematology)

National Institute of Blood Diseases and Bone Marrow Transplantation

- Present

M.B;B.S

Dow University of Health Sciences

2004 - 2009

Certifications

• none

  None

  January 2025 - January 2025

Publications

JOURNAL ARTICLE

Bushra Kaleem, Sadaf Shahab, Tahir Sultan Shamsi (2024). Impacto de la mutación T315I en el pronóstico de la leucemia mieloide crónica . Advances in Laboratory Medicine / Avances en Medicina de Laboratorio.

Bushra Kaleem, Sadaf Shahab, Tahir Sultan Shamsi (2024). T315I – a gatekeeper point mutation and its impact on the prognosis of chronic myeloid leukemia . Advances in Laboratory Medicine / Avances en Medicina de Laboratorio.

Bushra Kaleem, Sadaf Shahab, Uzma Zaidi, Tahir Sultan Shamsi(2022). P‐Loop mutations—Negative prognosticators in tyrosine kinase inhibitors resistant chronic myeloid leukemia patients . International Journal of Laboratory Hematology. Wiley

Kanani, F., Jamal, S., Khowaja, S., Kaleem, B., Anis, S., Iftikhar, S., Khursheed, N., Ansari, N.B.(2022). Sensitivity and Specificity of Anti-SARS-CoV-2 Detection Kits-Comparison and Agreement between Fifteen Different Assays . Japanese Journal of Infectious Diseases. 75. (1). p. 16-23.

Ansari, S.H., Hussain, Z., Zohaib, M., Parveen, S., Kaleem, B., Qamar, H., Adil, O., Khan, M.T., Shamsi, T.S.(2022). A Pragmatic Scoring Tool to Predict Hydroxyurea Response among β-Thalassemia Major Patients in Pakistan . Journal of Pediatric Hematology/Oncology. 44. (1). p. E77-E83.

Kanani, F., Anis, S., Kaleem, B., Jamal, S.(2022). Association of Seroconversion Status with Outcome in Admitted Covid-19 Patients . Journal of the College of Physicians and Surgeons Pakistan. 32. (7). p. 874-879.

Yaqoob, N., Mansoor, S., Zia, N., Aftab, K., Kaleem, B., Jamal, S.(2022). Chemotherapy induced histopathological changes in retinoblastoma, assessment of high risk predictive factors & its correlation with comorbid conditions . Pakistan Journal of Medical Sciences. 38. p. 362-368.

Yaqoob, N., Zia, N., Hamid, A., Kaleem, B., Jamal, S., Amin, S., Qaddoumi, I., Jamal, S.(2022). Correlation of clinical and radiological predictors of retinoblastoma with high-risk histopathological features . Pediatric Blood and Cancer. 69. (5).

Jamal, S., Mansoor, N., Kaleem, B., Lateef, F., Yaqoob, N.(2022). FREQUENCY, DISTRIBUTION OF SUBTYPES AND IMMUNOHISTOCHEMICAL PROFILE OF NON-HODGKIN LYMPHOMA IN PAEDIATRIC AND ADOLESCENT PATIENTS . Journal of Ayub Medical College. 34. (2). p. 351-356.

Yaqoob, N., Mansoor, S., Aftab, K., Kaleem, B., Hamid, A., Jamal, S.(2022). High risk histopathological factors in retinoblastoma in upfront enucleated eyes: An experience from a tertiary care centre of Pakistan . Pakistan Journal of Medical Sciences. 38. p. 369-374.

Kaleem, B., Shahab, S., Zaidi, U., Shamsi, T.S.(2022). P-Loop mutations—Negative prognosticators in tyrosine kinase inhibitors resistant chronic myeloid leukemia patients . International Journal of Laboratory Hematology. 44. (3). p. 538-546.

(2021). Chemotherapy induced histopathological changes in retinoblastoma, assessment of high risk predictive factors & its correlation with comorbid conditions. Pakistan Journal of Medical Sciences.

(2021). High risk histopathological factors in retinoblastoma in upfront enucleated eyes: An experience from a tertiary care centre of Pakistan. Pakistan Journal of Medical Sciences.

Sensitivities and specificities of Anti-SARS CoV2 detection kits - comparison and agreement between fifteen assays @article{2021, doi = {10.7883/yoken.jjid.2021.031}, url = {https://doi.org/10.7883%2Fyoken.jjid.2021.031}, year = 2021, month = {may}, publisher = {Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis}, author = {Fatima Kanani and Saba Jamal and Saira Khowaja and Bushra Kaleem and Sabiha Anis and Sundus Iftikhar and Nazia Khursheed and Naila Baig Ansari}, title = {Sensitivities and specificities of Anti-{SARS} {CoV}2 detection kits - comparison and agreement between fifteen assays}} . Japanese Journal of Infectious Diseases.

Sigma metrics of Alinity ci system- a study on thirty- nine clinical chemistry and immunoassay parameters @article{2021, doi = {10.1515/almed-2021-0025}, url = {https://doi.org/10.1515%2Falmed-2021-0025}, year = 2021, month = {apr}, publisher = {Walter de Gruyter {GmbH}}, volume = {2}, number = {2}, pages = {277--285}, author = {Fatima Zehra Kanani and Adnan Haider Kazmi and Bushra Kaleem}, title = {La m{\'{e}}trica Sigma del sistema Alinity ci: estudio sobre 39 magnitudes qu{\'{\i}}micas y de inmunoensayo}} . Advances in Laboratory Medicine.

(2021). Frequency, distribution of subtypes and immunohistochemical profile of Non-Hodgkin Lymphoma in pediatric and adolescent patients. Journal of Ayub Medical College.

A Pragmatic Scoring Tool to Predict Hydroxyurea Response Among β-Thalassemia Major Patients in Pakistan @article{2021, doi = {10.1097/mph.0000000000002136}, url = {https://doi.org/10.1097%2Fmph.0000000000002136}, year = 2021, month = {mar}, publisher = {Ovid Technologies (Wolters Kluwer Health)}, volume = {Publish Ahead of Print}, author = {Saqib H. Ansari and Zeeshan Hussain and Muhammad Zohaib and Sadia Parveen and Bushra Kaleem and Hina Qamar and Omair Adil and Muhammad T. Khan and Tahir S. Shamsi}, title = {A Pragmatic Scoring Tool to Predict Hydroxyurea Response Among $\upbeta$-Thalassemia Major Patients in Pakistan}} . Journal of Pediatric Hematology/Oncology.

Kanani, F.Z., Haider Kazmi, A., Kaleem, B.(2021). Sigma metrics of Alinity ci system - A study on thirty-nine clinical chemistry and immunoassay parameters . Advances in Laboratory Medicine. 2. (2). p. 267-275.

Kanani, F.Z., Kazmi, A.H., Kaleem, B.(2021). Sigma metrics of Alinity ci system: A study on 39 clinical chemistry and immunoassay parameters,La metrica Sigma del sistema Alinity ci: Estudio sobre 39 magnitudes quimicas y de inmunoensayo . Advances in Laboratory Medicine. 2. (2). p. 277-285.

A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients @article{2020, doi = {10.1186/s12885-020-6700-3}, url = {https://doi.org/10.1186%2Fs12885-020-6700-3}, year = 2020, month = {mar}, publisher = {Springer Science and Business Media {LLC}}, volume = {20}, number = {1}, author = {Uzma Zaidi and Gul Sufaida and Munazza Rashid and Bushra Kaleem and Sidra Maqsood and Samina Naz Mukry and Rifat Zubair Ahmed Khan and Saima Munzir and Munira Borhany and Tahir Sultan Shamsi}, title = {A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients}} . BMC Cancer.

Bushra Kaleem, Uzma Zaidi, Gul Sufaida, Munazza Rashid, Sidra Maqsood, Samina Naz Mukry, Rifat Zubair Ahmed Khan, Saima Munzir, Munira Borhany, Tahir Sultan Shamsi(2020). A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients . BMC Cancer. 20. (1). Springer Science and Business Media {LLC}

Zaidi, U., Sufaida, G., Rashid, M., Kaleem, B., Maqsood, S., Mukry, S.N., Khan, R.Z.A., Munzir, S., Borhany, M., Shamsi, T.S.(2020). A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients . BMC Cancer. 20. (1).

(2019). Pattern of Antimicrobial Sensitivity in Microbiologically Documented Infections in Neutropenic Patients with Haematological Malignancies: A single Center Study . Indian Journal of Microbiology.

Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients</p> @article{2019, doi = {10.2147/cmar.s181911}, url = {https://doi.org/10.2147%2Fcmar.s181911}, year = 2019, month = {feb}, publisher = {Informa {UK} Limited}, volume = {Volume 11}, pages = {1493--1502}, author = {Uzma Zaidi and Bushra Kaleem and Munira Borhany and Sidra Maqsood and Naveena Fatima and Gul Sufaida and Saqib Ansari and Tasneem Farzana and Tahir Sultan Shamsi}, title = {$\less$p$\greater$Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients$\less$/p$\greater$}} . Cancer Management and Research.

Laboratory diagnosis for thalassemia intermedia: Are we there yet? @article{2018, doi = {10.1002/jcla.22647}, url = {https://doi.org/10.1002%2Fjcla.22647}, year = 2018, month = {sep}, publisher = {Wiley}, volume = {33}, number = {1}, pages = {e22647}, author = {Saqib Ansari and Nabil Rashid and Anny Hanifa and Saima Siddiqui and Bushra Kaleem and Arshi Naz and Kousar Perveen and Zeeshan Hussain and Iqra Ansari and Qammar Jabbar and Tahir Khan and Muhammad Nadeem and Tahir Shamsi}, title = {Laboratory diagnosis for thalassemia intermedia: Are we there yet?}} . Journal of Clinical Laboratory Analysis.

Jamal, A., Fatima, N., Shaikh, S., Kaleem, B., Rizvi, Q.A., Zaidi, U., Borhany, M., Shamsi, T.(2019). Pattern of Antimicrobial Sensitivity in Microbiologically Documented Infections in Neutropenic Patients with Haematological Malignancies: A single Center Study . Indian Journal of Microbiology. 59. (2). p. 188-192.

Zaidi, U., Kaleem, B., Borhany, M., Maqsood, S., Fatima, N., Sufaida, G., Ansari, S.H., Farzana, T., Shamsi, T.S.(2019). Early and sustained deep molecular response achieved with nilotinib in high Sokal risk chronic myeloid leukemia patients . Cancer Management and Research. 11. p. 1493-1502.

Ansari, S., Rashid, N., Hanifa, A., Siddiqui, S., Kaleem, B., Naz, A., Perveen, K., Hussain, Z., Ansari, I., Jabbar, Q., et al.(2019). Laboratory diagnosis for thalassemia intermedia: Are we there yet? . Journal of Clinical Laboratory Analysis. 33. (1).

Ansari, S.H., Parveen, S., Siddiqui, S., Perveen, K., Ahmed, G., Kaleem, B., Ahmed, S., Zohaib, M., Farzana, T., Shamsi, T.(2018). Managing thalassemia in the developing world: An evidence-based approach for prevention, transfusion independency, and curative treatment with hematopoietic stem cell transplantation . Blood Advances. 2. p. 42-45.

Clinical and Laboratory Parameters in a Cohort of CLL Patient: A Single Centre Experience @article{2017, doi = {10.15406/htij.2017.05.00128}, url = {https://doi.org/10.15406%2Fhtij.2017.05.00128}, year = 2017, month = {nov}, publisher = {{MedCrave} Group, {LLC}}, volume = {5}, number = {4}, author = {Mehwesh Taj}, title = {Clinical and Laboratory Parameters in a Cohort of {CLL} Patient: A Single Centre Experience}} . Hematology & Transfusion International Journal.

Chronic Myeloid Leukemia - Prognostic Value of Mutations @article{2015, doi = {10.7314/apjcp.2015.16.17.7415}, url = {https://doi.org/10.7314%2Fapjcp.2015.16.17.7415}, year = 2015, month = {dec}, publisher = {Asian Pacific Organization for Cancer Prevention}, volume = {16}, number = {17}, pages = {7415--7423}, author = {Bushra Kaleem and Sadaf Shahab and Nuzhat Ahmed and Tahir Sultan Shamsi}, title = {Chronic Myeloid Leukemia - Prognostic Value of Mutations}} . Asian Pacific Journal of Cancer Prevention.

Plasma Cell Leukemia-Behind a Disguise @article{2015, doi = {10.4172/2165-7920.1000533}, url = {https://doi.org/10.4172%2F2165-7920.1000533}, year = 2015, publisher = {{OMICS} Publishing Group}, volume = {05}, number = {05}, author = {Bushra Kaleem}, title = {Plasma Cell Leukemia-Behind a Disguise}} . Journal of Clinical Case Reports.

Kaleem, B., Shahab, S., Ahmed, N., Shamsi, T.S.(2015). Chronic myeloid leukemia - Prognostic value of mutations . Asian Pacific Journal of Cancer Prevention. 16. (17). p. 7415-7423.

CONFERENCE PAPER

Managing thalassemia in the developing world: an evidence-based approach for prevention, transfusion independency, and curative treatment with hematopoietic stem cell transplantation @article{2018, doi = {10.1182/bloodadvances.2018gs112057}, url = {https://doi.org/10.1182%2Fbloodadvances.2018gs112057}, year = 2018, month = {nov}, publisher = {American Society of Hematology}, volume = {2}, number = {Supplement{\_}1}, pages = {42--45}, author = {Saqib Hussain Ansari and Sadia Parveen and Saima Siddiqui and Kousar Perveen and Ghazala Ahmed and Bushra Kaleem and Shariq Ahmed and Muhammad Zohaib and Tasneem Farzana and Tahir Shamsi}, title = {Managing thalassemia in the developing world: an evidence-based approach for prevention, transfusion independency, and curative treatment with hematopoietic stem cell transplantation}} . Blood Advances.